Você procurou por: 21:34 (Dinamarquês - Inglês)

21/ 34 9.
21/ 34 8.

21% (10 til 34) cmax:
21% (10 to 34) cmax:

auc: ↑ 21% (↑ 10 til ↑ 34)
auc: j 21% (j 10 to j 34)

artikel 21 (saa artikel 34)
article 21 (saa article 34)

ê 2002/21/ef betragtning 34
ê 2002/21/ec recital 34

artikel 19, 21, 25, 34 og 35
articles 19, 21, 25, 34 and 35

2, 6, 14, 21, 26, 34 og 35
2, 6, 14, 21, 26, 34 and 35

21% (9- 34) 12% (2- 23)
21% (9-34) 12% (2-23)

21) artikel 34 erstattes af følgende artikler:
article 34 shall be replaced by the following articles:

21 – 31%, 23 – 34% og 23 – 49%).
in clinical trials of various efavirenz-containing regimens in treatment naive patients, total cholesterol, hdl-cholesterol, and triglycerides increased over 48 weeks of treatment (21 - 31%, 23 - 34%, and 23 - 49%, respectively).

Ændring 21, 26-27, 34, 41, 85rev.
amendments 21, 26-27, 34, 41, 85rev.

tlf: +45 44 20 11 00 tel : + 356 21 34 46 10
tlf: +45 44 20 11 00 tel: +35621 344610

34% (21 til 41) cmax:
34% (21 to 41) cmax:

tlf. (1)723 34 21
tel. (1)723 34 21

100g, sector 6 bucureti tel.: + 40 (0) 21 408 63 34
b-dul timioara, nr.100g, sector 6bucuretitel.: + 40 (0) 21 408 63 34

nace 17, 18, 21, 24, 27, 28, 31, 32 og 34
nace 17, 18, 21, 24, 27, 28, 31, 32, 34

fax (34) 915 21 98 32
fax: (34) 915 21 98 32

amgen s. a.tel: +351 21 4220550 tel: +34 93 600 19 00
tel: +351 21 4220550

telefax (34) 915 21 98 32 og (34) 915 22 43 87 .
fax (34) 915 21 98 32 and (34) 915 22 43 87

tlf. (32.2) 515 87 21 - fax: (32.2) 515 85 34.
tel. (32.2)515 87 21 - fax (32.2)515 85 34.